The company’s abstract, titled “Osteoinductivity and Osteogenicity of Leading Allograft Bone Products,” analyzed the bone forming potential of the company’s two allograft products, OsteoAMP Allogeneic Morphogenetic Protein and Osteocel Plus.
The study has been submitted for an additional peer review.
More Articles on Devices:
DePuy Extends Brainlab Collaboration on Spine Instrumentation
Thompson Surgical Instruments Celebrates 50 Years, Launches New Products
K2M Launches SANTORINI Cage System for Spinal Vertebral Collapse, Damage
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
